129 related articles for article (PubMed ID: 8138403)
1. Thermoluminescence measurements of gamma-ray doses attributable to fallout from the Nevada test site using building bricks as natural dosimeters.
Haskell EH; Bailiff IK; Kenner GH; Kaipa PL; Wrenn ME
Health Phys; 1994 Apr; 66(4):380-91. PubMed ID: 8138403
[TBL] [Abstract][Full Text] [Related]
2. The Utah Thyroid Cohort Study: analysis of the dosimetry results.
Till JE; Simon SL; Kerber R; Lloyd RD; Stevens W; Thomas DC; Lyon JL; Preston-Martin S
Health Phys; 1995 Apr; 68(4):472-83. PubMed ID: 7883559
[TBL] [Abstract][Full Text] [Related]
3. Historical estimates of external gamma exposure and collective external gamma exposure from testing at the Nevada Test Site. I. Test series through HARDTACK II, 1958.
Anspaugh LR; Church BW
Health Phys; 1986 Jul; 51(1):35-51. PubMed ID: 3332000
[TBL] [Abstract][Full Text] [Related]
4. Historical estimates of external gamma exposure and collective external gamma exposure from testing at the Nevada Test Site. II. Test series after Hardtack II, 1958, and summary.
Anspaugh LR; Ricker YE; Black SC; Grossman RF; Wheeler DL; Church BW; Quinn VE
Health Phys; 1990 Nov; 59(5):525-32. PubMed ID: 2211112
[TBL] [Abstract][Full Text] [Related]
5. Estimates of doses from global fallout.
Bouville A; Simon SL; Miller CW; Beck HL; Anspaugh LR; Bennett BG
Health Phys; 2002 May; 82(5):690-705. PubMed ID: 12003019
[TBL] [Abstract][Full Text] [Related]
6. Intercomparison of luminescence measurements of bricks from Dolon' village: experimental methodology and results from Japanese laboratory.
Sato H; Hoshi M; Takada J
J Radiat Res; 2006 Feb; 47 Suppl A():A23-8. PubMed ID: 16571941
[TBL] [Abstract][Full Text] [Related]
7. Estimates of exposure rates and fallout arrival times near the Nevada Test Site.
Thompson CB
Health Phys; 1990 Nov; 59(5):555-63. PubMed ID: 2211115
[TBL] [Abstract][Full Text] [Related]
8. Intercomparison of luminescence measurements of bricks from Dolon' village: experimental methodology and results of European Study Group.
Göksu HY; Stepanenko VF; Bailiff IK; Jungner H;
J Radiat Res; 2006 Feb; 47 Suppl A():A29-37. PubMed ID: 16571942
[TBL] [Abstract][Full Text] [Related]
9. Individual external exposures from Nevada Test Site fallout for Utah leukemia cases and controls.
Lloyd RD; Gren DC; Simon SL; Wrenn ME; Hawthorne HA; Lotz TM; Stevens W; Till JE
Health Phys; 1990 Nov; 59(5):723-37. PubMed ID: 2211126
[TBL] [Abstract][Full Text] [Related]
10. Radiation exposures in Utah from Nevada Nuclear Tests.
Beck HL; Krey PW
Science; 1983 Apr; 220(4592):18-24. PubMed ID: 6828876
[TBL] [Abstract][Full Text] [Related]
11. The Utah Leukemia Case-Control Study: dosimetry methodology and results.
Simon SL; Till JE; Lloyd RD; Kerber RL; Thomas DC; Preston-Martin S; Lyon JL; Stevens W
Health Phys; 1995 Apr; 68(4):460-71. PubMed ID: 7883558
[TBL] [Abstract][Full Text] [Related]
12. Comments on estimates of external gamma exposure from testing at the Nevada Test Site.
Neel JW; Rowland RH
Health Phys; 1988 Jun; 54(6):674-5. PubMed ID: 3378900
[No Abstract] [Full Text] [Related]
13. The application of retrospective luminescence dosimetry in areas affected by fallout from the semipalatinsk nuclear test site: an evaluation of potential.
Bailiff IK; Stepanenko VF; Göksu HY; Jungner H; Balmukhanov SB; Balmukhanov TS; Khamidova LG; Kisilev VI; Kolyado IB; Kolizshenkov TV; Shoikhet YN; Tsyb AF
Health Phys; 2004 Dec; 87(6):625-41. PubMed ID: 15545769
[TBL] [Abstract][Full Text] [Related]
14. Radioactive fallout reconstruction from contemporary measurements of reservoir sediments.
Krey PW; Heit M; Miller KM
Health Phys; 1990 Nov; 59(5):541-54. PubMed ID: 2211114
[TBL] [Abstract][Full Text] [Related]
15. A cohort study of thyroid disease in relation to fallout from nuclear weapons testing.
Kerber RA; Till JE; Simon SL; Lyon JL; Thomas DC; Preston-Martin S; Rallison ML; Lloyd RD; Stevens W
JAMA; 1993 Nov; 270(17):2076-82. PubMed ID: 8411574
[TBL] [Abstract][Full Text] [Related]
16. Comparison of retrospective luminescence dosimetry with computational modeling in two highly contaminated settlements downwind of the Chernobyl NPP.
Bailiff IK; Stepanenko VF; Göksu HY; Bøtter-Jensen L; Brodski L; Chumak V; Correcher V; Delgado A; Golikov V; Jungner H; Khamidova LG; Kolizshenkov TV; Likhtarev I; Meckbach R; Petrov SA; Sholom S
Health Phys; 2004 Jan; 86(1):25-41. PubMed ID: 14695006
[TBL] [Abstract][Full Text] [Related]
17. Ground-based air-sampling measurements near the Nevada Test Site after atmospheric nuclear tests.
Cederwall RT; Ricker YE; Cederwall PL; Homan DN; Anspaugh LR
Health Phys; 1990 Nov; 59(5):533-40. PubMed ID: 2211113
[TBL] [Abstract][Full Text] [Related]
18. Overview of the National Cancer Institute's activities related to exposure of the public to fallout from the Nevada Test Site.
Wachholz BW
Health Phys; 1990 Nov; 59(5):511-4. PubMed ID: 2211110
[TBL] [Abstract][Full Text] [Related]
19. Optically stimulated luminescence in retrospective dosimetry.
Bøtter-Jensen L; Murray AS
Radiat Prot Dosimetry; 2002; 101(1-4):309-14. PubMed ID: 12382758
[TBL] [Abstract][Full Text] [Related]
20. Ingestion of Nevada Test Site fallout: internal dose estimates.
Whicker FW; Kirchner TB; Anspaugh LR; Ng YC
Health Phys; 1996 Oct; 71(4):477-86. PubMed ID: 8830749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
